Logo

Recruiting for HIV Clinical Studies during COVID-19: Challenges and Solutions - Shared screen with speaker view
HU CFAR
26:31
GO!
Dr. Li
33:47
Please ask your questions to the speakers and panelists in the chat box
Michael Louella
36:11
I’m struck by the term “scientific common sense”. Could you define what you mean by that?
Michael Louella
40:00
Investment seems ti be beyond my ability as an outreach manager whose funding ends every five years. What can I do to see such investments in my communities grow?
Dr. Tashima
42:35
Katie and Nina, just want to let you know that I asked to go next due to patients that I will need to see at 11. I"m sorry to throw a change in but I thank you in advance
Dr. Stephenson
43:03
No worries!
Dr. Juelg
44:45
100 attendees!
Dr. Burchett
48:28
Should not only be at the table but the participants are for whom the research is done so should be at the head of the table
Moka Jeong
49:22
will today’s recording be available somewhere? i missed the first presentation
Dr. Li
51:52
Hi Moka, HU CFAR has a YouTube channel. Alberto/Amanda, can we make sure that the symposium is available?
Laurenia Mangum
53:02
can you share the contact info for the previous speaker please?
HU CFAR
55:08
This is the link to all of the speaker and panelist biographies https://cfar.globalhealth.harvard.edu/files/cfar/files/symposium_biographies_for_jan_14_2021.pdf?m=1610560286
Moka Jeong
55:28
thanks
Dr. Li
56:44
Hi Laurenia, Dr. Ojikutu's email is: BOJIKUTU@mgh.harvard.edu
Heidi Bright
56:51
Looking at community engagement - are you only looking to connect with organizations that are funded by local, state or federal resources?
Dr. Li
57:03
Hi Laurenia, Dr. Ojikutu's email is: BOJIKUTU@mgh.harvard.edu
Dr. Li
57:57
Hi Moka, the Harvard University CFAR has a YouTube channel. We will make sure that the symposium is available
Dr. Ojikutu
59:03
Hi Heidi I hope that you are doing well. Not at all. The funding source doesn't matter. Let's reconnect.
Heidi Bright
01:07:27
please check out HOCC's newest initiative HOCC on the Go.. reaching nearly 100 women every month - hoccprograms.org under Faces and Voices of HOCC.
HU CFAR
01:09:19
Dr. Raj Gandhi's question for Dr Tashima: "Our IRBs in March and April moved very quickly to approve COVID trials. Do you think going forward there may by efficiencies that we learned during that time that we can apply to future research?
Dr. Li
01:11:37
Why don't we move Raj's Q to the panel discussion?
Dr. Tashima
01:11:52
sounds great
Dr. Tashima
01:17:14
going to jump off, but hope to get back on to join the panel!
Steve Willis
01:18:52
Dr Stephenson: can you talk about specific IRB support for the disruptions in your trials?
Dr. Stephenson
01:20:41
Jumping off one sec to answer a patient question
Julia Tripp
01:42:17
This is just a comment: this is quite enlightening for me as a PLWA, having been quite isolated during this pandemic, especially the intent and the challenges of engaging PLWA in Covid 19 vaccine research and maintaining or managing HIV care. This is a seminar I needed! Excellent work and thank you to all of you for this incredibly difficult work. It saddens me to hear about the economic challenges for research participants and various literacy issues
HU CFAR
01:51:24
thank you for your meaningful comment, Julia. We might want to use it when posting the recording on our website if OK with you. Hope you are well :) -Alberto
Carol Tyrell
01:51:38
what is Adrianna's email ? missed it on the last slide
Julia Tripp
01:52:35
Absolutely.... Im so grateful for this seminar and each presentation.... so important, so good
HU CFAR
01:52:36
Adrianna Boulin <ABoulin@fenwayhealth.org>
Dr. Li
01:55:20
Thanks Julia!
Heidi Bright
01:55:58
good to see you Paul!
Michael Louella
02:00:14
Can you tell us more about PrEP being confused with cure? WHat do they say when you attempt to correct them?
Dr. Li
02:04:55
Alberto/Amanda, when the YouTube video is uploaded, can you email a link to all of the speakers/panelists? It would be great to also link to it from the HU CFAR website. Thanks!
Dr. Li
02:05:42
This has been really informative so far. Amazing talks everyone!
HU CFAR
02:07:47
Yes, for sure. We will put the video on our youtube channel and website and can share in a tweet. We technically only have a permission slip back from Boris so far in order to do so, but we will follow-up on that.
Carol Tyrell
02:08:08
what questions should participants ask if they are interested in a clinical trial?
Dr. Li
02:09:07
Alberto, do you have the slide?
Julia Tripp
02:09:29
Thank you Paul for that presentation and connecting the disinformation and trust associated with the current soon-to-be-ended administration and the impact on HIV/Covid 19 efforts!
Mr. Goulet
02:09:51
Hey Heidi,
Mr. Goulet
02:10:06
Hope that yo are doing well!
Mr. Goulet
02:10:25
Hi Michael,
Mr. Goulet
02:12:15
When I say that PrEP is a prevention method many times is but if I’m on PrEP I won’t get HIV, without understanding adherence, STI transmission , etc. PrEP for many is an end all be all.
Sara Looby
02:22:30
Thanks for an informative presentation!
Dr. Li
02:22:50
This symposium will be put on the Harvard CFAR YouTube channel and there will be a link to it from the CFAR website.
Rajesh Gandhi
02:26:23
Fantastic presentations -- great symposium!!
Amy McManus
02:26:54
Thank you very much, excellent presentations!